In a legal career spanning more than 20 years, Maria Grazia has become a trusted point of reference for those multinational companies in the Life Sciences & Healthcare and Real Estate development sectors that intend to locate their business in Italy.
She is Head of the Life Sciences and Healthcare team in Italy and as Osborne Clarke’s Italian specialist in each of these sectors, she heads up an experienced team that counsels a multinational client base.
Her specialism in life sciences and pharmaceuticals draws on technical acumen acquired while working with the industry, and it’s this practical knowledge that means her clients receive razor-sharp insight and guidance daily.
The advice she provides covers the many complex areas, including litigation, facing the sector, such as: the production and sale of pharmaceutical products, active ingredients, medical devices, and food supplements; regulatory procedures for the granting of market authorisation, pricing and reimbursement of medicinal products; and representing clients before the regulatory agencies and in proceedings before the administrative courts.
Maria Grazia also counsels Italian and international companies in the development, construction, and operation of real-estate complexes to be used for office, sanitary, retail and leisure use. At the same time, she has built over two decades’ experience assisting clients in the cinema sector, including advising on cinema advertising.
Maria Grazia is included in Legal 500's Hall of Fame in the category Industry focus: Healthcare and life sciences. She is admitted to appear before the Italian Supreme Court.
A team of experts operating at the highest of levels and led by a person with an eye that is always trained on the business’ requirements.
Helping you succeed in tomorrow's world
I have always held the belief that a good lawyer is a good listener – and someone with the practical expertise to guide each client towards their specific objectives.
Insights
Compassionate Use in Europe
Farmindustria releases updated Code Of Ethics
Is Italy's new law on rare diseases a starting or end point?
Medical device advertising in Italy: is authorisation by the Ministry of Health still required?
2022 Finance Act increases State investment in Italian national health system
Global healthcare's embrace of patient support programmes spurs regulatory action
Are European advertising laws ready for patient support programmes?
Telemedicine on the rise in Europe
The European telemedicine industry is on the rise as a result of recent legalisation of activities such as remote treatment...
Preliminary remarks on the Italian Government's additional Covid-19 emergency measures
On 12 March 2020 a new Prime Minister decree (the “Second Decree”) entered into force in Italy, following the previous...
Preliminary remarks on the Italian Government's urgent provisions for COVID-19
Osborne Clarke has prepared a report to help clients dealing with the various legal issues arising from the DPCM 8...